Thomas Murray was Appointed as Director, Information Security and Privacy at Karyopharm

Date of management change: July 18, 2019 

What Happened?

Newton, Massachusetts-based Karyopharm Appointed Thomas Murray as Director, Information Security and Privacy

 

About the Company

Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm`s SINE compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharm`s lead compound, XPOVIO™ (selinexor), received accelerated approval from the FDA in July 2019 in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma. A Marketing Authorization Application for selinexor is also currently under review by the European Medicines Agency. In addition to single-agent and combination activity against a variety of human cancers, SINE compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm has several investigational programs in clinical or preclinical development.

 

About the Person

Thomas Murray is Director, Information Security and Privacy at Karyopharm. Previously, Thomas held various senior IT leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Gabriel Michael, McCarthy Robert, Ulmer David, McKenna Michelle, Chilukuri Sateesh, Armstrong Justin, Guzman Laura, Repenning Jack, Arthur Steve, Campbell Chris, Waddell Sean

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.